News Image

Why NYSE:BMA qualifies as a CANSLIM stock.

By Mill Chart

Last update: Sep 6, 2024

Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if BANCO MACRO SA-ADR (NYSE:BMA) is suited for growth investing. Investors should of course do their own research, but we spotted BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, so it may be worth spending some more time on it.


High Growth stocks image

Some of the canslim metrics of NYSE:BMA highlighted

  • The quarterly earnings of BANCO MACRO SA-ADR have shown a 3.0K% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
  • BANCO MACRO SA-ADR has achieved 668.0% growth in its revenue over the previous quarter, signaling positive momentum in its financial performance and potential market opportunities.
  • Over the past 3 years, BANCO MACRO SA-ADR has demonstrated 170.0% growth in EPS, signifying its positive financial trajectory and potential for future profitability.
  • BANCO MACRO SA-ADR showcases a robust Return on Equity (ROE) of 25.68%, indicating its ability to generate favorable returns for shareholders. This metric underscores the company's efficiency in utilizing its equity capital to generate profits.
  • BANCO MACRO SA-ADR has achieved an impressive Relative Strength (RS) rating of 98.33, showcasing its ability to outperform the broader market. This strong performance positions BANCO MACRO SA-ADR as an attractive stock for potential price appreciation.
  • Maintaining a Debt-to-Equity ratio of 0.14, BANCO MACRO SA-ADR demonstrates a conservative financial approach. This signifies the company's focus on minimizing debt burdens while preserving a solid equity position.
  • BANCO MACRO SA-ADR demonstrates a balanced ownership structure, with institutional shareholders at 8.37%. This indicates a diverse investor base, which can contribute to price stability and potential future growth.

Analyzing the Technical Aspects

Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.

Taking everything into account, BMA scores 10 out of 10 in our technical rating. Both in the recent history as in the last year, BMA has proven to be a steady performer, scoring decent points in every aspect analyzed.

  • Both the short term and long term trends are positive. This is a very positive sign.
  • Looking at the yearly performance, BMA did better than 98% of all other stocks. On top of that, BMA also shows a nice and consistent pattern of rising prices.
  • BMA is part of the Banks industry. There are 402 other stocks in this industry. BMA outperforms 99% of them.
  • BMA is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
  • In the last month BMA has a been trading in the 48.40 - 65.99 range, which is quite wide. It is currently trading near the high of this range.
  • Volume is considerably higher in the last couple of days, which is what you like to see during a strong movement up.
  • Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.

Our latest full technical report of BMA contains the most current technical analsysis.

Fundamental Analysis Observations

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

Overall BMA gets a fundamental rating of 4 out of 10. We evaluated BMA against 402 industry peers in the Banks industry. BMA may be in some trouble as it scores bad on both profitability and health. BMA shows excellent growth, but is valued quite expensive already.

Check the latest full fundamental report of BMA for a complete fundamental analysis.

More growth stocks can be found in our CANSLIM screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back